Helminth 2-Cys peroxiredoxin drives Th2 responses through a mechanism involving alternatively activated macrophages

FASEB Journal

Volumn 22, Issue 11, 2008, Pages 4022-4032

  Donnelly, Sheila ^a   Stack, Colin M ^a   O'Neill, Sandra M ^b   Sayed, Ahmed A ^c   Williams, David L ^c   Dalton, John P ^a,d  

^a UNIVERSITY OF TECHNOLOGY SYDNEY   (Australia)

^b DUBLIN CITY UNIVERSITY   (Ireland)

^c ILLINOIS STATE UNIVERSITY   (United States)

^d UNIVERSITY OF TECHNOLOGY SYDNEY   (Australia)

Author keywords

Antioxidant; Immune modulation; Innate immunity

Indexed keywords

CYSTEINE; IMMUNOGLOBULIN G; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; PEROXIREDOXIN; QUIL A; RECOMBINANT PEROXIREDOXIN; UNCLASSIFIED DRUG;

ADJUVANT THERAPY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN SPECIFICITY; ANTIOXIDANT ACTIVITY; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FASCIOLA HEPATICA; FEMALE; HELMINTH; HELMINTHIASIS; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOMODULATION; IN VITRO STUDY; MACROPHAGE; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; SCHISTOSOMA MANSONI; TH2 CELL; WESTERN BLOTTING; WILD TYPE;

ANIMALS; ANTIGENS, DIFFERENTIATION; CELLS, CULTURED; DISEASE MODELS, ANIMAL; FASCIOLA HEPATICA; FASCIOLIASIS; FEMALE; HELMINTH PROTEINS; IMMUNIZATION; IMMUNIZATION, PASSIVE; INTERLEUKIN-13; INTERLEUKIN-4; MACROPHAGE ACTIVATION; MACROPHAGES; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; PEROXIREDOXINS; RECOMBINANT PROTEINS; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS MANSONI; SIGNAL TRANSDUCTION; TH2 CELLS;

FASCIOLA HEPATICA; MURINAE; MUS; SCHISTOSOMA MANSONI; VERMES;

EID: 55549093092     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.08-106278     Document Type: Article

References (52)

1. Mantovani, A., Sozzani, S., Locati, M., Allavena, P., and Sica, A. (2002) Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 23, 549-555
2. Noël, W., Raes, G., Hassanzadeh Ghassabeh, G., De Baetselier, P., and Beschin, A. (2004) Alternatively activated macrophages during parasite infections. Trends Parasitol. 20, 126-133
3. Anthony, R. M., Urban, J. F. Jr., Alem, F., Hamed, H. A., Rozo, C. T., Boucher, J. L., Van Rooijen, N., and Gause, W. C. (2006) Memory T(H)2 cells induce alternatively activated macrophages to mediate protection against nematode parasites. Nat. Med. 12, 955-960
4. Zhu, Z., Zheng, T., Homer, R. J., Kim, Y. K., Chen, N. Y., Cohn, L., Hamid, Q., and Elias, J. A. (2004) Acidic mammalian chitinase in asthmatic Th2 inflammation and IL-13 pathway activation. Science 304, 678-682
5. Sinha, P., Clements, V. K., and Ostrand-Rosenberg, S. (2005) Interleukin-13-regulated M2 macrophages in combination with myeloid suppressor cells block immune surveillance against metastasis. Cancer Res. 65, 11743-11751
6. Gordon, S. (2003) Alternative activation of macrophages. Nat. Rev. Immunol. 3, 23-35
7. Raes, G., De Baetselier, P., Noël, W., Beschin, A., Brombacher, F., and Hassanzadeh, Gh. G. (2002) Differential expression of FIZZ1 and Ym1 in alternatively versus classically activated macrophages. J. Leukoc. Biol. 71, 597-602
8. Edwards, J. P., Zhang, X., Frauwirth, K. A., and Mosser, D. M. (2006) Biochemical and functional characterization of three activated macrophage populations. J. Leukoc. Biol. 80, 1298-1307
9. Loke, P., Nair, M. G., Parkinson, J., Guiliano, D., Blaxter, M., and Allen, J. E. (2002) IL-4 dependent alternatively-activated macrophages have a distinctive in vivo gene expression phenotype. BMC Immunol. 3, 7
10. Loke, P., MacDonald, A. S., and Allen, J. E. (2000) Antigen-presenting cells recruited by Brugia malayi induce Th2 differentiation of naïve CD4(-) T cells. Eur. J. Immunol. 30, 1127-1135
11. Hayashi, N., Matsui, K., Tsutsui, H., Osada, Y., Mohamed, R. T., Nakano, H., Kashiwamura, S., Hyodo, Y., Takeda, K., Akira, S., Hada, T., Higashino, K., Kojima, S., and Nakanishi, K. (1999) Kupffer cells from Schistosoma mansoni-infected mice participate in the prompt type 2 differentiation of hepatic T cells in response to worm antigens. J. Immunol. 163, 6702-6711
12. Herbert, D. R., Holscher, C., Mohrs, M., Arendse, B., Schwegmann, A., Radwanska, M., Leeto, M., Kirsch, R., Hall, P., Mossmann, H., Claussen, B., Forster, I., and Brombacher, F. (2004) Alternative macrophage activation is essential for survival during schistosomiasis and downmodulates T helper 1 responses and immunopathology. Immunity 20, 623-635
13. Atochina, O., Daly-Engel, T., Piskorska, D., McGuire, E., and Harn, D. A. (2001) A schistosome-expressed immunomodulatory glycoconjugate expands peritoneal Gr1(-+) macrophages that suppress naive CD4(-+) T cell proliferation via an IFN-gamma and nitric oxide-dependent mechanism J. Immunol. 167, 4293-4302
14. Brys, L., Beschin, A., Raes, G., Ghassabeh, G. H., Noël, W., Brandt, J., Brombacher, F., and De Baetselier, P. (2005) Reactive oxygen species and 12/15-lipoxygenase contribute to the antiproliferative capacity of alternatively activated myeloid cells elicited during helminth infection. J. Immunol. 174, 6095-6104
15. Jin, H. M., Copeland, N. G., Gilbert, D. J., Jenkins, N. A., Kirkpatrick, R. B., and Rosenberg, M. (1998) Genetic characterization of the murine Ym1 gene and identification of a cluster of highly homologous genes. Genomics 54, 316-322
16. Hung, S. I., Chang, A. C., Kato, I., and Chang, N. C. (2002) Transient expression of Ym1, a heparin-binding lectin, during developmental hematopoiesis and inflammation. J. Leukoc. Biol. 72, 72-82
17. Arora, M., Chen, L., Paglia, M., Gallagher, I., Allen, J. E., Vyas, Y. M., Ray, A., and Ray, P. (2006) Simvastatin promotes Th2-type responses through the induction of the chitinase family member Ym1 in dendritic cells. Proc. Natl. Acad. Sci. U. S. A. 103, 7777-7782
18. Falcone, F. H., Loke, P., Zang, X., MacDonald, A. S., Maizels, R. M., and Allen, J. E. (2001) A Brugia malayi homolog of macrophage migration inhibitory factor reveals an important link between macrophages and eosinophil recruitment during nematode infection. J. Immunol. 167, 5348-5354
19. Crabtree, J. E., and Wilson, R. A. (1986) The role of pulmonary cellular reactions in the resistance of vaccinated mice to Schistosoma mansoni. Parasite Immunol. 8, 265-285
20. McManus, D. P., and Dalton, J. P. (2006) Vaccines against the zoonotic trematodes Schistosoma japonicum, Fasciola hepatica and Fasciola gigantica. Parasitology 133, S43-61
21. Mulcahy, G., O'Neill, S., Donnelly, S., and Dalton, J. P. (2004) Helminths at mucosal barriers - interaction with the immune system. Adv. Drug Deliv. Rev. 56, 853-868
22. Pearce, E., J., Kane, C. M., Sun, J. J., Taylor, J., McKee, A. S., and Cervi, L. (2004) Th2 response polarization during infection with the helminth parasite Schistosoma mansoni. Immunol. Rev. 201, 117-126
23. Street, M., Coulson, P. S., Sadler, C., Warnock, L. J., McLaughlin, D., Bluethmann, H., and Wilson, R. A. (1999) TNF is essential for the cell-mediated protective immunity induced by the radiation-attenuated Schistosome vaccine. J. Immunol. 163, 4489-4494
24. Donnelly, S., O'Neill, S. M., Sekiya, M., Mulcahy, G., and Dalton, J. P. (2005) Thioredoxin peroxidase secreted by Fasciola hepatica induces the alternative activation of macrophages. Infect. Immun. 73, 166-173
25. O'Neill, S. M., Brady, M. T., Callahan, J. J., Mulcahy, G., Joyce, P., Mills, K. H., and Dalton, J. P. (2000) Fasciola hepatica infection downregulates Th1 responses in mice. Parasite Immunol. 22, 147-155
26. Pearce, E. J., Caspar, P., Grzych, J. M., Lewis, F. A., and Sher, A. (1991) Downregulation of Th1 cytokine production accompanies induction of Th2 responses by a parasitic helminth, Schistosoma mansoni. J. Exp. Med. 173, 159-166
27. Grzych, J. M., Pearce, E., Cheever, A., Caulada, Z.A., Caspar, P., Heiny, S., Lewis, F., and Sher, A. (1991) Egg deposition is the major stimulus for the production of Th2 cytokines in murine schistosomiasis mansoni. J. Immunol. 4, 1322-1327
28. Sekiya, M., Mulcahy, G., Irwin, J. A., Stack, C. M., Donnelly, S. M., Xu, W., Collins, P., and Dalton, J. P. (2006) Biochemical characterisation of the recombinant peroxiredoxin (FhePrx) of the liver fluke, Fasciola hepatica. FEBS Lett. 580, 5016-5022
29. Stack, C. M., Donnelly, S., Lowther, J., Xu, W., Collins, P. R., Brinen, L. S., and Dalton, J. P. (2007) The major secreted cathepsin L1 protease of the liver fluke, Fasciola hepatica: a Leu-12 to Pro-12 replacement in the nonconserved C-terminal region of the prosegment prevents complete enzyme autoactivation and allows definition of the molecular events in prosegment removal. J. Biol. Chem. 282, 16532-16543
30. Sayed, A. A., and Williams, D. L. (2004) Biochemical characterization of 2-Cys peroxiredoxins from Schistosoma mansoni. J. Biol. Chem. 279, 26159-26166
31. Collins, P. R., Stack, C. M., O'Neill, S. M., Doyle, S., Ryan, T., Brennan, G. P., Mousley, A., Stewart, M., Maule, A. G., Dalton, J. P., and Donnelly, S. (2004) Cathepsin L1, the major protease involved in liver fluke (Fasciola hepatica) virulence: propetide cleavage sites and autoactivation of the zymogen secreted from gastrodermal cells. J. Biol. Chem. 279, 17038-17046
32. Aida, Y., and Pabst, M. J. (1991) Removal of endotoxin from protein solutions by phase separation using Triton X-114. J. Immunol. Methods 132, 191-195
33. Williams, D. L., Asahi, H., Botkin, D. J., and Stadecker, M. J. (2001) Schistosome infection stimulates host CD4(+-) T helper cell and B-cell responses against a novel egg antigen, thioredoxin peroxidase. Infect. Immun. 69, 1134-1141
34. Kumagai, T., Osada, Y., and Kanazawa, T. (2006) 2-Cys peroxiredoxins from Schistosoma japonicum: the expression profile and localization in the life cycle. Mol. Biochem. Parasitol. 149, 135-143
35. Cass, C. L., Johnson, J. R., Califf, L. L., Xu, T., Hernandez, H. J., Stadecker, M. J., Yates, J.R. 3rd, and Williams, D. L. (2007) Proteomic analysis of Schistosoma mansoni egg secretions. Mol. Biochem. Parasitol. 155, 84-93
36. McGonigle, S., Dalton, J. P., and James, E. R. (1998) Peroxidoxins: a new antioxidant family. Parasitol. Today 14, 139-145
37. Henkle-Duhren, K., and Kampkotter, A. (2001) Antioxidant enzyme families in parasitic nematodes. Mol. Biochem. Parasitol. 114, 129-142
38. Maizels, R. M. (2004) Helminth parasites-masters of regulation. Immunol. Rev. 201, 89-116
39. MacDonald, A. S., Araujo, M. I., and Pearce, E. J. (2002) Immunology of parasitic helminth infections. Infect. Immun. 70, 427-433
40. Atochina, O., Da'dara, A. A., Walker, M., and Harn, D. A. (2008) The immunomodulatory glycan LNFPIII initiates alternative activation of murine macrophages in vivo. Immunology 125, 111-121
41. Kreider, T., Anthony, R. M., Urban, J. F. Jr., and Gause, W. C. (2007) Alternatively activated macrophages in helminth infections. Curr. Opin. Immunol. 19, 448-453
42. Hofmann, B., Hecht, H. J., and Flohé, L. (2002) Peroxiredoxins. Biol. Chem. 383, 347-364
43. European Patent Application No. 97925196.4 (0953047).
44. Callahan, H. L., Crouch, R. K., and James, E. R. (1988) Helminth anti-oxidant enzymes: a protective mechanism against host oxidants? Parasitol. Today 4, 218-225
45. Mu, Z. M., Yin, X. Y., and Prochownik, E. V. (2002) Pag, a putative tumor suppressor, interacts with the Myc Box II domain of c-Myc and selectively alters its biological function and target gene expression. J. Biol. Chem. 277, 43175-43184
46. Wen, S. T., and Van Etten, R. A. (1997) The PAG gene product, a stress-induced protein with antioxidant properties, is an Abl SH3-binding protein and a physiological inhibitor of c-Abl tyrosine kinase activity. Genes Dev. 11, 2456-2467
47. Giguère, P., Turcotte, M. E., Hamelin, E., Parent, A., Brisson, J., Laroche, G., Labrecque, P., Dupuis, G., and Parent, J. L. (2007) Peroxiredoxin-4 interacts with and regulates the thromboxane A2 receptor. FEBS Lett. 581, 3863-3868
48. Park, S. Y., Yu, X., Ip, C., Mohler, J. L., Bogner, P. N., and Park, Y. M. (2007) Peroxiredoxin 1 interacts with androgen receptor and enhances its transactivation. Cancer Res. 67, 9294-9303
49. Wood, Z. A., Schroder, E., Harris, J. R., and Poole, L. B. (2003) Structure, mechanism and regulation of peroxiredoxins. Trends Biochem. 28, 32
50. Chang, J. W., Lee, S. H., Jeong, J. Y., Chae, H. Z., Kim, Y. C., Park, Z. Y., and Yoo, Y. J. (2005) Peroxiredoxin-I is an autoimmunogenic tumor antigen in non-small cell lung cancer. FEBS Lett. 579, 2873
51. Kang, S. W., Rhee, S. G., Chang, T., Jeong, W., Choi, M. H. (2005) 2-Cys peroxiredoxin function in intracellular signal transduction: therapeutic implications. Trends Mol. Med. 11, 571
52. Sica, A., and Bronte, V. (2007) Altered macrophage differentiation and immune dysfunction in tumor development. J. Clin. Invest. 117, 1155-1166